The institutional investor held 181,469 shares of the health care company at the end of 2017Q3, valued at $9.87M, down from 210,550 at the end of the previous reported quarter. Capital International Sarl who had been investing in Seattle Genetics Inc for a number of months, seems to be bullish on the $8.07 billion market cap company.
Seattle Genetics (NASDAQ:SGEN) traded up $0.49 during mid-day trading on Tuesday, reaching $56.08. About 1.97M shares traded. F.N.B.
Seattle Genetics (NASDAQ:SGEN)'s stock had its "hold" rating reissued by stock analysts at JPMorgan Chase & Co.in a research note issued to investors on Tuesday, January 9th. It has outperformed by 58.98% the S&P500.
Bluecrest Capital Management Ltd decreased Fnb Corp Pa (FNB) stake by 87.62% reported in 2017Q3 SEC filing. The company has market cap of $8.07 billion. The stock increased 0.49% or $0.33 during the last trading session, reaching $68.04. About 37,439 shares traded or 17.86% up from the average. (NYSE:GWR) has risen 13.88% since January 28, 2017 and is uptrending. It has underperformed by 12.42% the S&P500.
Since August 7, 2017, it had 0 insider buys, and 18 selling transactions for $10.97 million activity. HELLMANN JOHN C sold $926,918 worth of stock. Tredje AP fonden grew its holdings in Seattle Genetics by 3.7% during the second quarter. (NYSE:GWR) was sold by Liucci Christopher F on Tuesday, August 29. The stock was sold at an average price of $60.91, for a total value of $2,398,940.35. Tiaa Cref Invest Mngmt Limited Com has 744,719 shares.
Bluecrest Capital Management Ltd increased Veon Ltd stake by 262,841 shares to 571,594 valued at $2.39M in 2017Q3. Therefore 54% are positive. RBC Capital Markets maintained the stock with "Outperform" rating in Friday, July 31 report. Piper Jaffray maintained Lowe's Companies, Inc. (NYSE:GWR) rating on Friday, November 10. (NYSE:LOW) has "Buy" rating given on Friday, January 5 by Barclays Capital. Cowen & Co maintained the stock with "Outperform" rating in Tuesday, August 4 report. The firm has "Neutral" rating given on Monday, December 12 by Credit Suisse. (NASDAQ:SGEN) has "Hold" rating given on Monday, July 24 by Oppenheimer. Susquehanna maintained Genesee & Wyoming Inc. Also, the Hold rating count is 0, as of 26 Jan 2018. The company has a consensus rating of "Hold" and an average target price of $63.76. RBC Capital Markets maintained Genesee & Wyoming Inc. (NYSE:NKE) rating on Thursday, December 14. Goldman Sachs maintained the stock with "Buy" rating in Wednesday, April 6 report. $1.22 million worth of Seattle Genetics, Inc. (NYSE:GWR) to report earnings on February, 14. During the same period in the prior year, the firm earned ($0.23) earnings per share. 985.62 million shares or 0.88% less from 994.42 million shares in 2017Q2 were reported.
Investors sentiment decreased to 0.78 in Q3 2017. Its up 0.08, from 0.99 in 2017Q2. 17,500 are owned by Utah Retirement Systems. Point72 Asia (Hong Kong) Ltd holds 59 shares or 0% of its portfolio. Bristlecone Advisors LLC acquired a new position in Seattle Genetics during the third quarter worth $180,000. Corporation (NYSE:FNB) for 32,400 shares. The consensus earnings estimates for the company have stabilized at US$-0.38 per share. Ruggie Capital Group Inc stated it has 572 shares or 0.02% of all its holdings. Ny State Teachers Retirement reported 0% stake. Ontario - Canada-based Royal Fincl Bank Of Canada has invested 0.01% in Seattle Genetics, Inc. Glenmede Trust Com Na holds 0% or 8,000 shares in its portfolio.
Olstein Capital Management Lp, which manages about $769.90M and $775.69M US Long portfolio, decreased its stake in Oracle Corp (NYSE:ORCL) by 15,000 shares to 327,000 shares, valued at $15.81 million in 2017Q3, according to the filing. Insiders own 34.70% of the company's stock. (NASDAQ:SGEN). The Pennsylvania-based Pnc Inc has invested 0% in Seattle Genetics, Inc. Envestnet Asset Management holds 0% or 1,567 shares. First Lp stated it has 0.09% of its portfolio in Seattle Genetics, Inc. (NYSE:GWR) for 2,745 shares. Wellington Management Grp Inc Llp reported 0% stake.
Investors sentiment decreased to 0.78 in Q3 2017. Its up 0.01, from 1.03 in 2017Q2. It dived, as 51 investors sold Seattle Genetics, Inc. shares while 74 reduced holdings.
A number of hedge funds have recently made changes to their positions in the business. 140.23 million shares or 2.00% more from 137.48 million shares in 2017Q2 were reported. (NASDAQ:SGEN). 871,816 are held by Deutsche Bank Ag. Commerzbank Aktiengesellschaft Fi invested in 50,037 shares or 0.04% of the stock. Cantor Fitzgerald set a $46.00 price target on Seattle Genetics and gave the stock a "hold" rating in a report on Monday, October 2nd. Amer Century Cos owns 2.62 million shares. New York-based Tower Rech Cap Ltd Co (Trc) has invested 0% in Seattle Genetics, Inc. (NASDAQ:SGEN). South Dakota Council accumulated 49,900 shares or 0.06% of the stock. $295,110 worth of Seattle Genetics, Inc. Tradewinds Mgmt Limited Co has invested 0.07% in Seattle Genetics, Inc. (NASDAQ:SGEN) or 18,832 shares. Seattle Genetics has a 1 year low of $45.31 and a 1 year high of $71.32. Cetera Advsr Lc invested in 57,862 shares or 0.18% of the stock. Strs Ohio reported 0% stake. Nebraska-based Ameritas Invest Prns has invested 0.06% in F.N.B. 306,694 are held by Lagoda Invest Mngmt Limited Partnership. Drw Securities accumulated 0.13% or 8,000 shares. It also reduced its holding in Starbucks Corp (NASDAQ:SBUX) by 16,000 shares in the quarter, leaving it with 433,902 shares, and cut its stake in Iron Mountain Inc (Reit) (NYSE:IRM). One research analyst has rated the stock with a sell rating, twelve have issued a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. Therefore 39% are positive. Guggenheim reiterated a "buy" rating and issued a $72.00 price objective on shares of Seattle Genetics in a research report on Monday, October 23rd. (NASDAQ:SGEN) has "Buy" rating given on Friday, October 27 by H.C. Wainwright. (NASDAQ:SGEN) on Thursday, July 27 with "Hold" rating. The firm earned "Hold" rating on Monday, June 19 by Cantor Fitzgerald. The firm has "Overweight" rating by Morgan Stanley given on Wednesday, September 7. The firm earned "Hold" rating on Thursday, October 19 by Keefe Bruyette & Woods. As per Wednesday, August 16, the company rating was maintained by Oppenheimer.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.
House Intel Could Vote Today; UPDATE FBI
As to DOJ complaints, Gowdy said last week, "to my friend Stephen Boyd, let's lower the rhetoric". They said it inaccurately summarizes investigative materials that also are classified.
Investor's Watch List: JC Penney Company Inc (JCP)
Jefferies Group set a $3.00 price target on J C Penney and gave the stock a "hold" rating in a report on Friday, October 27th. Since January 1, 0001, it had 0 insider purchases, and 6 selling transactions for $2.20 million activity.